HTG is a life science company advancing precision medicine by leveraging its innovative transcriptome-wide profiling technology to develop profiling diagnostics and novel drug candidates to determine the right therapy for the right patient.

News & Events

HTG and Icahn School of Medicine at Mount Sinai Announce Bladder Cancer Research Collaboration

HTG’s Innovative Transcriptome Panel Technology to be Leveraged in Retrospective Studies TUCSON, Ariz. , Nov. 17, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling…

Keep Reading

HTG Molecular Diagnostics Reports Third Quarter 2021 Results

Call scheduled for today, November 10, at 4:30 pm ET TUCSON, Ariz. , Nov. 10, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported its…

Keep Reading

HTG Molecular Diagnostics to Announce Third Quarter 2021 Financial Results and Host Conference Call on Wednesday, November 10

TUCSON, Ariz. , Nov. 02, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a life science company advancing precision medicine through its transcriptome-wide technology, today announced that it will report its financial results for the third quarter ended September 30, 2021…

Keep Reading

Publications

Read white papers or journal publications and view other scientific content. 

White Papers

Posters

Abstracts

Webinars

Peer Reviewed Publications

Editorials

Reviews


Careers at HTG

At HTG, we are always looking for talented individuals to help us deliver our next-generation sequencing-based products throughout the world.

New Careers

Commercial Lab Technician

Buyer

Marketing Manager / Product Manager

See All Careers


Page last updated November 09, 2021